Cargando…
Applications of patient-derived tumor xenograft models and tumor organoids
Patient-derived tumor xenografts (PDXs), in which tumor fragments surgically dissected from cancer patients are directly transplanted into immunodeficient mice, have emerged as a useful model for translational research aimed at facilitating precision medicine. PDX susceptibility to anti-cancer drugs...
Autor principal: | Yoshida, Go J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947974/ https://www.ncbi.nlm.nih.gov/pubmed/31910904 http://dx.doi.org/10.1186/s13045-019-0829-z |
Ejemplares similares
-
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021) -
Organoid models of the tumor microenvironment and their applications
por: Xia, Tao, et al.
Publicado: (2021) -
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
por: Pham, Nhu-An, et al.
Publicado: (2021) -
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023) -
Organoid and Spheroid Tumor Models: Techniques and Applications
por: Gunti, Sreenivasulu, et al.
Publicado: (2021)